Related to the decision of Hacettepe University Senate on January 25th, 2017 (decision number 2017-55), name of the Hacettepe University, Center for Biobanking and Genomics (HUBIGEM) was suggested to be changed as Hacettepe University, Center for Genomics and Rare Diseases and the Steering Committee of Higher Education approved the name change on February 22nd, 2017 in compliance with Law 2547, Number 2880, item 7/d-2.
Center was established after Regulations of the Center was published in Official Newspaper, numbered 30127, on July 18th, 2017.
Center’s aims of establishment:
- To produce researches that have capacity to be translated from the basic science researches towards the diagnosis and treatment of rare diseases and commercialization of products from these researches,
- To increase the capacity of biobanking in rare diseases and to provide this infrastructure for the improvement of researches in basic sciences, drug targets, discovery of biomarkers, personalization of treatment areas through the use of high-technology in genomics and efforts in education, application and scientific researches or collaboration with ongoing researches,
- To design collaborative research projects in bioinformatics for the clarification of the clinical significance of the large scale genomic data obtained from the researches in rare diseases.
- To continue the development of new diagnostic tools and treatment modalities in rare diseases,
- To establish a national registry for rare diseases and the harmonization of this registry with the international systems,
- To provide service and consultancy in the use of technologies in genomics in the diagnosis and treatment of rare diseases,
- To provide consultancy to the Ministries and Funders in order to support the scientific policies in the use of technologies in genomics in the field of rare diseases,
- To transfer the knowledge in the subject through educational activities such as institutional/out of institution, national/international, seminars, conferences, workshops, courses etc.,
- To increase public awareness on the use of technologies of genomics in diagnosis and treatment of rare diseases, through the appropriate use of these technologies and to provide appropriate supply and demand,
- To provide diagnosis and treatment service for the patients in neighborhood countries through the collaborative work of stakeholders in the field including current healthcare providers, researchers, faculties,
- To ensure sustainability in patient services and to increase visibility in the international area through the studies designed as a role of national coordination center in rare diseases and genomics and clinical/basic researches.